Lonna J. Williams Stolper has served on the Sanford Burnham Prebys Board of Trustees since 2023.
She is currently director of the Rady Children’s Institute for Genomic Medicine, the UCLA Health Advisory Board and former CEO and director of Ridge Diagnostics, with previous experience in managing early-stage companies involved in early life cycle diagnostic and pharmacogenetic product and market development, and in collaborations with such companies as Glaxo-Wellcome and Eli Lilly. She assisted in the founding of Alastin Skincare, acquired by Galderma, a Swiss-based pharmaceutical company, in 2022.
Stolper previously served as a director of the International Bipolar Foundation and other for-profit and non-profit boards.
She has a Bachelor of Science degree from Colorado State University and completed graduate studies at the University of Colorado and the UCLA Anderson School of Management.